Apaf-1 is a transcriptional target for E2F and p53
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Loss of function of the retinoblastoma protein, pRB, leads to lack of differentiation, hyperproliferation and apoptosis. Inactivation of pRB results in deregulated E2F activity, which in turn induces entry to S-phase and apoptosis. Induction of apoptosis by either the loss of pRB or the deregulation of E2F activity occurs via both p53-dependent and p53-independent mechanisms. The mechanism by which E2F induces apoptosis is still unclear. Here we show that E2F1 directly regulates the expression of Apaf-1, the gene for apoptosis protease-activating factor 1. These results provide a direct link between the deregulation of the pRB pathway and apoptosis. Furthermore, because the pRB pathway is functionally inactivated in most cancers, the identification of Apaf-1 as a transcriptional target for E2F might explain the increased sensitivity of tumour cells to chemotherapy. We also show that, independently of the pRB pathway, Apaf-1 is a direct transcriptional target of p53, suggesting that p53 might sensitize cells to apoptosis by increasing Apaf-1 levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“abnormal proliferation that is induced by loss of RB is often accompanied by increased cell death, through p53-dependent and independent mechanisms49,57,87–91.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [90]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 1×
“Consistent with this role, the pRB pathway is deregulated in most human cancers (reviewed in ref”
BackgroundThe regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · cited 1×
“The best-characterized targets for the pRB family members are the E2F transcription factor”
BackgroundA Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523 · cited 1×
“Increased levels of Apaf-1 as a result of increased E2F activity could provide an explanation for the greater sensitivity of tumour cells to a variety of apoptosis-inducing agents, including chemotherapeutic drug”
BackgroundApaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development
Yoshida, H., Kong, Y.-Y., Yoshida, R., Elia, A. J., Hakem, A., Hakem, R., Penninger, J. M., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81733-x · Cited by 1,138 · cited 1×
“Apaf-1 is an essential stimulator of caspase activity and is required for stress- and oncogene-induced apoptosi”
BackgroundThe coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant
Goldstein, J. C., Waterhouse, N. J., Juin, P., Evan, G. I., & Green, D. R. (2000) · Nature Cell Biology · doi:10.1038/35004029 · Cited by 1,071
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966 · cited 1×
“This suggestion was further substantiated by results—published while this manuscript was undergoing review—showing that Apaf-1 expression is lost in a number of malignant melanomas owing to a combination of allelic loss and transcriptional silencin”
Resultp73 is a human p53-related protein that can induce apoptosis
Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948
p14ARF links the tumour suppressors RB and p53
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H. (1998) · Nature · doi:10.1038/25867 · Cited by 918
Cited by
Items 101–200 of 707
E2F1 is crucial for E2F‐dependent apoptosis
Denchi, E. L., & Helin, K. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400452 · Cited by 142
“…we envision that increased E2F1 activity leads to apoptosis through an ARF–p53dependent pathway as well as p53-independent pathways, which include the activation of E2F1 target genes such as APAF1 and p73 or of CHK2 (Irwin et al, 2000; Moroni et al, 2001; Kang et al, 2002; Rogoff et al, 2004).”
BackgroundMethodSelf-citationThe Aryl Hydrocarbon Receptor Binds to E2F1 and Inhibits E2F1-induced Apoptosis
Marlowe, J. L., Fan, Y., Chang, X., Peng, L. H., Knudsen, E. S., Xia, Y., & Puga, A. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-04-0359 · Cited by 141
“A direct test of this hypothesis made use of the Saos-2 human osteosarcoma cells, in which E2F1 overexpression and stabilization have been shown to induce apoptosis (Moroni et al., 2001; Stevens et al., 2003).”
MethodChoi, S.-S., Lew, K. L., Xiao, H., Herman-Antosiewicz, A., Xiao, D., Brown, C., & Singh, S. V. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl144 · Cited by 141
Hershko, T., Chaussepied, M., Oren, M., & Ginsberg, D. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401575 · Cited by 137
Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP
Potts, M. B., Vaughn, A. E., McDonough, H., Patterson, C., & Deshmukh, M. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504082 · Cited by 116
“Because E2F1 has been identified as a transcriptional regulator of Apaf-1 (Moroni et al., 2001), the reduced activity of E2F1 in terminally differentiated cardiomyocytes (Flink et al.”
BackgroundE2F1-induced apoptosis: turning killers into therapeutics
Stanelle, J., & Pützer, B. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.02.002 · Cited by 135
E2F-7: a distinctive E2F family member with an unusual organization of DNA-binding domains
Logan, N., Delavaine, L., Graham, A., Reilly, C., Wilson, J. R., Brummelkamp, T. R., Hijmans, E. M., Bernards, R., & Thangue, N. B. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207649 · Cited by 136
“…was generated by subcloning the 346 bp BglII/XhoI Ad5 DNA fragment containing 62 bp coding for the first leader segment and 284 bp upstream of the cap site of the E2A promoter (La Thangue and Rigby, 1987) into pGL3-Basic (Promega). pApaf1-luc has been previously described (Moroni et al., 2001).”
Methodp53 downstream targets and chemosensitivity
Sax, J. K., & El‐Deiry, W. S. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401227 · Cited by 133
“Recent evidence has shown that Apaf-1 is a target of both E2F and p53.(37) Either the pRb or the p53 pathways are deregulated in most types of tumors.”
BackgroundWu, Z., Zheng, S., Li, Z. M., Qiao, Y., Aau, M. Y., & Yu, Q. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.162 · Cited by 132
Impairment of p53 acetylation, stability and function by an oncogenic transcription factor
Insinga, A., Monestiroli, S., Ronzoni, S., Carbone, R., Pearson, M. A., Pruneri, G., Viale, G., Appella, E., Pelicci, P. G., & Minucci, S. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600109 · Cited by 132
“These cells were engineered to express the p53-estrogen receptor chimera The EMBO Journal VOL 23 | NO 5 | 2004 &2004 European Molecular Biology Organization1148 (p53ER), a p53 conditional allele activated by 4-hydroxytamoxifen (OHT) treatment (Moroni et al, 2001).”
BackgroundMethodTranscriptional Regulation of AKT Activation by E2F
Chaussepied, M., & Ginsberg, D. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.003 · Cited by 129
Cancer chemoresistance: The relationship between p53 and multidrug transporters
Bush, J. A., & Li, G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10226 · Cited by 116
Regulation of Geminin and Cdt1 expression by E2F transcription factors
Yoshida, K., & Inoue, I. (2004) · Oncogene · doi:10.1038/sj.onc.1207488 · Cited by 128
Tumour suppressor genes in chemotherapeutic drug response
Lai, D., Grieve, S., & Yang, X. (2012) · Bioscience Reports · doi:10.1042/bsr20110125 · Cited by 131
Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.
Saavedra, H. I., Wu, L., de Bruin, A., Timmers, C. D., Rosol, T. J., Weinstein, M. B., Robinson, M. L., & Leone, G. W. (2002) · PubMed · Cited by 125
New roles for the RB tumor suppressor protein
Liu, H., Dibling, B. C., Spike, B. T., Dirlam, A., & Macleod, K. F. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.005 · Cited by 122
A Gene Signature-Based Approach Identifies mTOR as a Regulator of p73
Rosenbluth, J. M., Mays, D. J., Pino, M. F., Tang, L. J., & Pietenpol, J. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00305-08 · Cited by 112
Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation
Ashur-Fabian, O., Avivi, A., Trakhtenbrot, L., Adamsky, K., Cohen, M., Kajakaro, G., Joel, A., Amariglio, N., Nevo, E., & Rechavi, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404998101 · Cited by 112
The yin and yang of E2F-1: balancing life and death
Thangue, N. B. L. (2003) · Nature Cell Biology · doi:10.1038/ncb0703-587 · Cited by 120
p53-Defective Tumors With a Functional Apoptosome-Mediated Pathway: A New Therapeutic Target
Mashima, T., Oh-hara, T., Sato, S., Mochizuki, M., Sugimoto, Y., Yamazaki, K., Hamada, J.-I., Tada, M., Moriuchi, T., Ishikawa, Y., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji133 · Cited by 114
Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1.
Ma, Y., Cress, W. D., & Haura, E. B. (2003) · PubMed · Cited by 120
Heightened Expression of CTCF in Breast Cancer Cells Is Associated with Resistance to Apoptosis
Docquier, F., Farrar, D., D'Arcy, V., Chernukhin, I. V., Robinson, A. F., Loukinov, D., Vatolin, S., Pack, S., Mackay, A. G., Harris, R. A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-03-3498 · Cited by 118
Harnessing apoptosis for improved anticancer gene therapy.
Waxman, D. J., & Schwartz, P. S. (2003) · PubMed · Cited by 117
The Phosphatase MKP1 Is a Transcriptional Target of p53 Involved in Cell Cycle Regulation
Li, M., Zhou, J.-Y., Ge, Y., Matherly, L. H., & Wu, G. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307149200 · Cited by 103
Identification of E-Box Factor TFE3 as a Functional Partner for the E2F3 Transcription Factor
Giangrande, P. H., Hallstrom, T. C., Tunyaplin, C., Calame, K., & Nevins, J. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.11.3707-3720.2003 · Cited by 104
“Similarly, the Apaf1 gene appears to be activated specifically by E2F1 (30).”
BackgroundWu, G. S., & Ding, Z. (2002) · Oncogene · doi:10.1038/sj.onc.1205020 · Cited by 113
“…or treated with adriamycin (0.2 mg/ml) for 24 h and total cellular protein was extracted for assessment of p53 expression by Western blot analysis using anti-human p53 monoclonal pAb1801 (Oncogene Science) Oncogene study showed that Apaf1 is a transcriptional target for p53 (Moroni et al., 2001).”
BackgroundMethodInfluentialQin, J., Chaturvedi, V., Denning, M. F., Bacon, P. E., Panella, J., Choubey, D., & Nickoloff, B. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205404 · Cited by 114
“Only slight changes in Bax, Bcl-x and Apaf-1 (a transcriptional target for p53; Moroni et al., 2001; Robles et al., 2001) at both protein and mRNA levels were observed in KCs exposed to UV-light between 25 and 100 mJ/cm2 (Figure 2a,b).”
BackgroundDifferential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis
Fusaro, G., Wang, S., & Chellappan, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205551 · Cited by 113
“…pathways, especially in receptor mediated cell death (Phillips et al., 1999); (2) induction of pro-apoptotic genes like p73 and Apaf-1 (Irwin et al., 2000; Lissy et al., 2000; Muller et al., 2001; Moroni et al., 2001); and (3) stabilization of p53 levels by inducing p14ARF (Bates et al., 1998).”
BackgroundThe Essential Role of Evasion from Cell Death in Cancer
Kelly, G. L., & Strasser, A. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-385524-4.00002-7 · Cited by 113
“The p53 induced bax transcription, like the p53 induced apaf-1 transcription (Moroni et al., 2001) most likely functions as a process for amplifying the apoptotic process rather than for deciding on whether a cell should live or die.”
BackgroundJazirehi, A. R., Gan, X.-H., de Vos, S., Emmanouilides, C. E., & Bonavida, B. (2003) · PubMed · Cited by 111
Regulation of Programmed Cell Death by the P53 Pathway
Kuribayashi, K., & El‐Deiry, W. S. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-1-4020-6554-5_10 · Cited by 109
A Role for 14-3-3τ in E2F1 Stabilization and DNA Damage-induced Apoptosis
Wang, B., Liu, K., Lin, F.-T., & Lin, W.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410493200 · Cited by 91
Marinelli, F., Sala, D. L., Cicciotti, G., Cattini, L., Trimarchi, C., Putti, S., Zamparelli, A., Giuliani, L., Tomassetti, G., & Cinti, C. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10425 · Cited by 109
“…p53dependent and -independent apoptosis since it can control accumulation of p53 (Hiebert et al., 1995; Kowalik et al., 1998), transcription of p73 (Irwin et al., 2000; Stiewe and Putzer, 2000; La Sala et al., 2003), and transcription of Apaf-1, a key element of apoptosome (Moroni et al., 2001).”
BackgroundSullivan, K. D., Gallant-Behm, C. L., Henry, R. E., Fraikin, J.-L., & Espinosa, J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.01.004 · Cited by 91
“ing components of the intrinsic (mitochondrial) pathway such as PUMA, NOXA, BID, BAX andAPAF1 [72,73,75,119–121], aswell asmembers of the extrinsic (death receptor) pathway such as FAS, DR4 and DR5/Killer [122–124].”
Wright, K. M., Linhoff, M. W., Potts, P. R., & Deshmukh, M. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200406073 · Cited by 94
“regulators of Apaf-1 (Moroni et al., 2001).”
BackgroundBig wheel keeps on turning: apoptosome regulation and its role in chemoresistance
Fadeel, B., Ottosson, A., & Pervaiz, S. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402265 · Cited by 108
“Apaf-1 is also a direct target for E2F (reference Moroni et al.(79)), another transcription factor that is capable of promoting both cell cycle progression and apoptosis, and Apaf-1 deficiency may impair the response to E2F-induced apoptosis.”
BackgroundCompensation and specificity of function within the E2F family
Kong, L.-J., Chang, J. T., Bild, A. H., & Nevins, J. R. (2006) · Oncogene · doi:10.1038/sj.onc.1209817 · Cited by 107
“These studies have identified a large number of genes that are regulated by E2F proteins that encode proteins necessary for cell cycle progression, DNA replication and mitosis (Ishida et al., 2001; Moroni et al., 2001; Muller et al., 2001; Polager et al., 2002).”
BackgroundDefects of the apoptotic pathway as therapeutic target against cancer
Mashima, T., & Tsuruo, T. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.11.001 · Cited by 106
Heazell, A. E. P., Sharp, A. N., Baker, P. N., & Crocker, I. P. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0551-3 · Cited by 105
“In normal cells p53 expression is maintained at low-levels, but following cell damage it is stabilised and/or activated, increasing p53 half-life from 30 min to 24 h [10, 11]. p53 has many roles including function as a transcription factor, promoting the expression of p21—a cell-cycle inhibitor [12] and Bax [13], PUMA…”
InfluentialEvolving intricacies and implications of E2F1 regulation
Mundle, S. D., & Saberwal, G. (2003) · The FASEB Journal · doi:10.1096/fj.02-0431rev · Cited by 84
Versatile functions of p53 protein in multicellular organisms
Chumakov, P. M. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907130019 · Cited by 84
Boutillier, A., Trinh, E., & Loeffler, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01581.x · Cited by 94
“Moreover, Apaf1 levels are increased in the CNS of Rb–/– embryos which exhibit a massive neuronal loss (Moroni et al. 2001).”
BackgroundThe E2F family and the role of E2F1 in apoptosis
Wu, Z., Zheng, S., & Yu, Q. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.06.004 · Cited by 101
“Therefore, Apaf-1 might play an important role in mediatng both p53-dependent and E2F1-dependent apoptosis in a certain ellular context (Moroni et al., 2001).”
BackgroundSignal-dependent protection from apoptosis in mice expressing caspase-resistant Rb
Chau, B. N., Borges, H. L., Chen, T.-T., Masselli, A., Hunton, I. C., & Wang, J. Y. J. (2002) · Nature Cell Biology · doi:10.1038/ncb853 · Cited by 102
The Proapoptotic Gene SIVA Is a Direct Transcriptional Target for the Tumor Suppressors p53 and E2F1
Fortin, A., MacLaurin, J. G., Arbour, N., Cregan, S. P., Kushwaha, N., Callaghan, S. M., Park, D. S., Albert, P. R., & Slack, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400376200 · Cited by 84
Emerging roles of RB family: New defense mechanisms against tumor progression
Indovina, P., Marcelli, E., Casini, N., Rizzo, V., & Giordano, A. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24170 · Cited by 103
“…as T antigen, E1A, and E7, sequester RB1/p105, thus releasing its physiological partner E2F1 and enabling it to carry out its proapoptotic function, through the regulation of the apoptotic peptidase activating factor 1 (APAF1) and caspase 3, 7, 8, and 9 (Moroni et al., 2001; Nahle et al., 2002).”
BackgroundE2F3 Is a Mediator of DNA Damage-Induced Apoptosis
Martinez, L. A., Goluszko, E., Chen, H., Leone, G. W., Post, S. M., Lozano, G., Chen, Z., & Chauchereau, A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00938-09 · Cited by 99
“In addition to regulating cell growth, the E2F transcription factors can promote apoptosis through the activation of deathinducing genes, such as p73, caspases, Apaf1 and Bcl-2 homology region 3 (BH3)-only proteins (9, 14, 24, 25, 27, 36).”
BackgroundHow the Other Half Lives: What p53 Does When It Is Not Being a Transcription Factor
Ho, T., Tan, B. X., & Lane, D. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010013 · Cited by 100
“Although p53 can upregulate the expression of BAX [96,97] and APAF-1 [98,99], this upregulation does not appear to be essential, as p53 null hematopoietic cells express the same levels of BAX and APAF-1 as their wildtype counterparts, and similarly undergo apoptosis [100].”
BackgroundApoptotic Pathways in Tumor Progression and Therapy
Melet, A., Song, K., Bucur, O., Jagani, Z., Grassian, A. R., & Khosravi‐Far, R. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-1-4020-6554-5_4 · Cited by 100
p53-Independent ceramide formation in human glioma cells during γ-radiation-induced apoptosis
Hara, S., Nakashima, S., Kiyono, T., Sawada, M., Yoshimura, S., Iwama, T., Banno, Y., Shinoda, J., & Sakai, N. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401428 · Cited by 99
Cell cycle proteins in Alzheimer's disease: Plenty of wheels but no cycle
Bowser, R., & Smith, M. A. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4316 · Cited by 92
“mechanisms such as Apaf-1 [28].”
Disruption of the Rb-Raf-1 Interaction Inhibits Tumor Growth and Angiogenesis
Dasgupta, P., Sun, J., Wang, S., Fusaro, G., Betts, V., Padmanabhan, J., Sebti, S. M., & Chellappan, S. P. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9527-9541.2004 · Cited by 98
“Rb has also been shown to possess antiapoptotic activity by repression of E2F1-regulated proapoptotic genes such as p73, Apaf-1, and caspase-3 (43, 51).”
BackgroundKrajewska, M., Kim, H., Kim, C., Kang, H., Welsh, K., Matsuzawa, S.-I., Tsukamoto, M., Thomas, R. G., Assa-Munt, N., Piao, Z., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0094 · Cited by 92
Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum
Ali, A., Farrand, L., Kim, J. Y., Byun, S., Suh, J., Lee, H. J., & Tsang, B. K. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06734.x · Cited by 99
p53, apoptosis and axon-guidance molecules
Arakawa, H. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401601 · Cited by 96
N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis
Liu, N., Wang, L., Li, X., Yang, Q., Liu, X., Zhang, J., Zhang, J., Wu, Y., Ji, S., Zhang, Y., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn504 · Cited by 96
Restoration of wild‐type p53 function in human cancer: Relevance for tumor therapy
Bossi, G., & Sacchi, A. (2007) · Head & Neck · doi:10.1002/hed.20529 · Cited by 88
Death squads enlisted by the tumour suppressor p53
Michalak, E., Villunger, A., Erlacher, M., & Strasser, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.183 · Cited by 94
Lau, D., & Bading, H. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0802-09.2009 · Cited by 83
“We found that two prominent, putative p53 target genes, apaf1 (Fortin et al., 2001; Moroni et al., 2001) and bbc3 [also known as p53-upregulated mediator of apoptosis ( puma)] (Nakano and Vousden, 2001; Yu et al., 2001) are also suppressed by AP bursting in an NMDA receptor-dependent manner (Fig.”
BackgroundMyc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts
Lindström, M. S., & Wiman, K. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206659 · Cited by 96
Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry
Lomazzi, M., Moroni, M. C., Jensen, M. R., Frittoli, E., & Helin, K. (2002) · Nature Genetics · doi:10.1038/ng891 · Cited by 93
Self-citationTransfer RNA gene recruitment in mitochondrial DNA
Lavrov, D. V., & Lang, B. F. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.01.004 · Cited by 98
Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma
Trejo‐Solís, C., Serrano‐García, N., Escamilla-Ramírez, Á., Castillo‐Rodríguez, R. A., Jiménez‐Farfán, D., Palencia, G., Calvillo, M., Lemus, M. A. A., Flores‐Nájera, A., Cruz-Salgado, A., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123773 · Cited by 93
“Tumor cells lead to an 584 increase in ROS levels, inducing autophagy in fibroblasts; in turn, this promotes glycolysis in stromal 585 cells, increasing the levels of pyruvate, lactate, acetoacetate, and 3-hydroxy-butyrate, which cover the 586 Figure 6.”
BackgroundInfluentialA role for the transcription factor HEY1 in glioblastoma
Hulleman, E., Quarto, M., Vernell, R., Masserdotti, G., Colli, E., Kros, J. M., Levi, D., Gaetani, P., Tunici, P., Finocchiaro, G., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00307.x · Cited by 84
“First, Northern blot analysis was performed using total RNA prepared from a human diploid fibroblast cell line, WI38, which expresses E2F1 fused to the ligand-binding domain of the oestrogen receptor [37, 38, 44].”
MethodSelf-citationFujimoto, A., Takeuchi, H., Taback, B., Hsueh, E. C., Elashoff, D. A., Morton, D. L., & Hoon, D. S. �. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2932 · Cited by 91
Oncoapoptotic signaling and deregulated target genes in cancers: Special reference to oral cancer
Khan, Z., & Bisen, P. S. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.04.002 · Cited by 90
“In some studies it has been reported that E2F can induce the expression of the proapoptotic factor Apaf-1 and evidence suggests a role for E2F in apoptosis following DNA damage [141,142] (Fig.”
BackgroundRamalho, R. M., Ribeiro, P. S., Solá, S., Castro, R. E., Steer, C. J., & Rodrigues, C. M. P. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02517.x · Cited by 82
Molecular changes in solitary fibrous tumor progression
Park, H. K., Yu, D. B., Sung, M., Oh, E., Kim, M., Song, J., Lee, M., Jung, K., Noh, K., An, S., et al. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01815-8 · Cited by 87
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Pinti, M., & Kroemer, G. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3504 · Cited by 74
“APAF1 p53 target gene (activator RE) Postmitochondrial mediator of intrinsic apoptosis (105, 162, 202)”
Luu, Y., Bush, J., Cheung, K. J., & Li, G. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5526 · Cited by 86
Apoptosis in inner ear sensory hair cells
Morrill, S., & He, D. Z. Z. (2017) · Journal of Otology · doi:10.1016/j.joto.2017.08.001 · Cited by 85
“…agents are not able to induce apoptosis, but sensitize cells to chemotherapeutic agents, improving apoptotic results, include Apaf1 and caspase-6 (MacLachlan and El-Deiry, 2002; Moroni et al., 2001; Sax and El-Deiry, 2003). p53 can also aid in apoptosis in a transcriptionally independent manner.”
BackgroundRegulation of Apoptosis by HER2 in Breast Cancer
Carpenter, R. L. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s7-003 · Cited by 85
“Inhibition of p53 expression greatly inhibits apoptosis as p53 has been shown to upregulate several pro-apoptotic genes involved in the intrinsic apoptotic pathway including PUMA [21], NOXA [22], APAF-1 [23], and Bax [24].”
BackgroundLi, C., Trudel, L. J., & Wogan, G. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162356399 · Cited by 85
Petrenko, O., Fingerle‐Rowson, G., Peng, T., Mitchell, R. A., & Metz, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211985200 · Cited by 84
Salon, C., Eymin, B., Micheau, O., Chaperot, L., Plumas, J., Brambilla, C., Brambilla, E. M., & Gazzéri, S. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401739 · Cited by 85
What have animal models taught us about the p53 pathway?
Lozano, G., & Zambetti, G. P. (2005) · The Journal of Pathology · doi:10.1002/path.1704 · Cited by 76
“Re-introduction of APAF-1 in defective melanoma cell lines restores chemosensitivity which is likely attributed to p53-dependent apoptotic activity.”
BackgroundInfluentialDrosophila E2F1 Has Context-Specific Pro- and Antiapoptotic Properties during Development
Moon, N.-S., Frolov, M. V., Kwon, E.-J., Stefano, L. D., Dimova, D. K., Morris, E. J., Taylor‐Harding, B., White, K., & Dyson, N. J. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.08.015 · Cited by 85
Schwartz, H. T., & Horvitz, H. R. (2007) · Genes & Development · doi:10.1101/gad.1607007 · Cited by 76
“Another conceivable mechanism to account for ced-9 Bcl-2-independent regulation of cell death is the cell cycle regulation of Apaf-1 transcription by the DP-E2F heterodimer (Moroni et al. 2001); however, we found that a loss-of-function mutation in the only DP homolog, dpl-1, did not affect CEM survival (data not show…”
p53 Is a Key Molecular Target of Ursodeoxycholic Acid in Regulating Apoptosis
Amaral, J. D., Castro, R. E., Solá, S., Steer, C. J., & Rodrigues, C. M. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704075200 · Cited by 78
Sun, H.-X., Xu, Y., Yang, X.-R., Wang, W.-M., Bai, H., Shi, R.-Y., Nayar, S. K., Devbhandari, R. P., He, Y.-Z., Zhu, Q.-F., et al. (2013) · Hepatology · doi:10.1002/hep.26188 · Cited by 79
Zhang, N., Zhu, J., Ma, Q., Zhao, Y. F., Wang, Y., Hu, X., Chen, J., Zhu, W. M., Han, Z., & Yu, H. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01782-9 · Cited by 82
“Apoptotic peptidase activating factor 1 (Apaf1) gene was found to be one of the predicted target genes for miR-136, and Apaf1 has been reported to play a crucial role in regulating cell survival and apoptosis [21].”
BackgroundKuwajima, T., Taniura, H., Nishimura, I., & Yoshikawa, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404143200 · Cited by 82
Li, C.-Q., Robles, A. I., Hanigan, C. L., Hofseth, L. J., Trudel, L. J., Harris, C. C., & Wogan, G. N. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1880 · Cited by 75
Modulation of pRb/E2F Functions in the Regulation of Cell Cycle and in Cancer
Seville, L., Shah, N., Westwell, A. D., & Chan, W. C. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053765816 · Cited by 81
Inactivation of E2F3 results in centrosome amplification
Saavedra, H. I., Maiti, B., Timmers, C. D., Altura, R. A., Tokuyama, Y., Fukasawa, K., & Leone, G. W. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00083-7 · Cited by 81
“At least in part, functional specificity among E2Fs in the control of centrosome duplication may reflect their ability to regulate distinct subsets of target genes (DeGregori et al., 1997; Ishida et al., 2001; Moroni et al., 2001; Muller et al., 2001).”
BackgroundCombinatorial gene control involving E2F and E Box family members
Giangrande, P. H., Zhu, W., Rempel, R. E., Laakso, N., & Nevins, J. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600134 · Cited by 81
“Conversely, E2F1 is a more potent inducer of apoptosis (DeGregori et al, 1997; Bates et al, 1998; Kowalik et al, 1998; Moroni et al, 2001; Lin et al, 2001; Leone et al, 2001).”
BackgroundDistinct gene expression phenotypes of cells lacking Rb and Rb family members.
Black, E. P., Huang, E. S., Dressman, H. K., Rempel, R. E., Laakso, N., Asa, S. L., Ishida, S., West, M., & Nevins, J. R. (2003) · PubMed · Cited by 81
Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain
Cross, B., Chen, L., Cheng, Q., Li, B., Yuan, Z.-M., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228981 · Cited by 70
“P53 can also induce PUMA, Noxa and Bid (Moroni et al., 2001; Nakano and Vousden, 2001; Oda et al., 2000a; Walensky et al., 2006).”
BackgroundDeath by design: where curcumin sensitizes drug-resistant tumours.
Saha, S., Adhikary, A., Bhattacharyya, P., Das, T., & Sa, G. (2012) · PubMed · Cited by 80
Solá, S., Ma, X., Castro, R. E., Kren, B. T., Steer, C. J., & Rodrigues, C. M. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300468200 · Cited by 80
Defects in the apoptotic machinery of cancer cells: role in drug resistance
Zhivotovsky, B., & Orrenius, S. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00130-x · Cited by 80
Zhang, X. P., Liu, F., & Wang, W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134650 · Cited by 80
Zhang, G., Zeng, X., Zhang, R., Liu, J., Zhang, W., Zhao, Y., Zhang, X., Wu, Z., Tan, Y., Wu, Y., et al. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.07.003 · Cited by 78
99mTc-MIBI in the evaluation of breast cancer biology
Vecchio, S. D., & Salvatore, M. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1530-0 · Cited by 78
Nuclear localization of Y-box factor YB1 requires wild-type p53
Zhang, Y. F., Homer, C. R., Edwards, S. J., Hananeia, L., Lasham, A., Royds, J. A., Sheard, P. W., & Braithwaite, A. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206357 · Cited by 78
Mason, S., Loughran, Ö., & Thangue, N. B. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205524 · Cited by 78
“The following reporters were used; Exon 1b-luc (Bates et al., 1998), Apa¯(7396/+208)-luc (Moroni et al., 2001), cyclinE-luc (Botz et al., 1996), 36WT and 36MT (Zamanian and La Thangue, 1992).”
BackgroundTranscriptional control of the core cell-death machinery
Kumar, S., & Cakouros, D. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.02.001 · Cited by 79
Jab1 is a specificity factor for E2F1-induced apoptosis
Hallstrom, T. C., & Nevins, J. R. (2006) · Genes & Development · doi:10.1101/gad.1345006 · Cited by 77
“…such as ARF, p73, APAF1, Casp3, Casp7, and Chk2, and by down-regulating expression of the anti-apoptotic genes Traf2 and Mcl1 (Bates et al. 1998; Irwin et al. 2000; Lissy et al. 2000; Stiewe and Putzer 2000; Moroni et al. 2001; Croxton et al. 2002; Nahle et al. 2002; Rogoff et al. 2002, 2004).”
BackgroundCell Cycle Proteins Exhibit Altered Expression Patterns in Lentiviral-Associated Encephalitis
Jordan-Sciutto, K. L., Wang, G., Murphey-Corb, M., & Wiley, C. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02185.2002 · Cited by 73
“ase , proliferating cell nuclear antigen, ribonucleotide reductase), and those that regulate cell death (apoptotic activating protein, p19) (Nevins, 1992; Farnham et al., 1993; LaThangue, 1994; Bates et al., 1998; Moroni et al., 2001).”
BackgroundTranscriptional control of stem cell fate by E2Fs and pocket proteins
Julian, L. M., & Blais, A. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00161 · Cited by 76
“References for cell death/survival genes are as follows: (Irwin et al., 2000; Moroni et al., 2001; Hershko and Ginsberg, 2004; Tracy et al., 2007).”
BackgroundInfluential
Metadata
- Authors
- Moroni, M. C., Hickman, E. S., Denchi, E. L., Caprara, G., Colli, E., Cecconi, F., Müller, H., & Helin, K.
- Affiliations
- European Institute of Oncology (IT)
- University of Rome Tor Vergata (IT)
- Nerviano Medical Sciences (IT)
- Corresponding author
- Helin, Kristian
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2001-05-10
- Volume
- 3
- Issue
- 6
- Pages
- 552-558
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W1497251274
- Cited by
- 593
- References
- 38
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 14 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 15 · 2014: 9 · 2013: 22 · 2012: 22
- FWCI
- 27.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Apaf-1, E2F1, p53, retinoblastoma protein, transcriptional regulation, apoptosis, chemosensitivity, cancer cells, S phase entry
- MeSH terms
- Animals, DNA-Binding Proteins, Embryo, Mammalian, Humans, Promoter Regions, Genetic, Proteins, Transcription Factors, Transcription, Genetic, Transcriptional Activation, Tumor Suppressor Protein p53, Retinoblastoma Protein, Cell Cycle Proteins, E2F Transcription Factors, E2F1 Transcription Factor, Mice, Apoptotic Protease-Activating Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.